Pursuant to Regulation 30, 33 and schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at its meeting held today, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Wardwizard Healthcare Ltd (formerly Ayoki Mercantile Ltd) on February 12, 2026 approved the unaudited standalone financial results for the third quarter and nine months ended December 31, 2025, along with the Limited Review Report by statutory auditor Mahesh Udhwani & Associates. Revenue from operations for the nine-month period fell sharply to about ₹80.9 lakh from ₹324.3 lakh in the same period last year, a decline of roughly 75%. The company reported a net loss of about ₹54.2 lakh for 9M FY26, narrowing somewhat from a ₹282.5 lakh loss a year ago, but still in the red. For Q3 FY26 alone, revenue stood at ₹7.85 lakh with a net loss of ₹18.5 lakh. The auditor flagged an Emphasis of Matter stating that the company did not carry out significant healthcare service activities during the quarter, and that management is re-strategizing its business and evaluating the feasibility of future operations.
The combination of steep revenue decline, persistent losses, and the auditor's emphasis on the company not running significant healthcare operations and reassessing its business feasibility is negative for shareholders and likely to weigh on the stock. Investors should watch for clarity from management on its new business strategy and any fundraising or restructuring plans.